0001558370-24-001840.txt : 20240227 0001558370-24-001840.hdr.sgml : 20240227 20240227161519 ACCESSION NUMBER: 0001558370-24-001840 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20240226 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20240227 DATE AS OF CHANGE: 20240227 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Virios Therapeutics, Inc. CENTRAL INDEX KEY: 0001818844 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 854314201 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39811 FILM NUMBER: 24686925 BUSINESS ADDRESS: STREET 1: 44 MILTON AVENUE CITY: ALPHARETTA STATE: GA ZIP: 30009 BUSINESS PHONE: 8666208655 MAIL ADDRESS: STREET 1: 44 MILTON AVENUE CITY: ALPHARETTA STATE: GA ZIP: 30009 FORMER COMPANY: FORMER CONFORMED NAME: Virios Therapeutics, LLC DATE OF NAME CHANGE: 20200721 8-K 1 tmb-20240226x8k.htm 8-K
0001818844false00018188442024-02-262024-02-26

​

​

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

​

FORM 8-K

​

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

​

Date of Report (Date of earliest event reported):  February 26, 2024

​

VIRIOS THERAPEUTICS, INC.

(Exact Name of Registrant as Specified in Charter)

​

​

​

​

Delaware

001-39811

85-4314201

(State or other jurisdiction
of incorporation)

(Commission
File Number)

(IRS Employer
Identification No.)

​

44 Milton Avenue
Alpharetta, GA 30009

(Address of Principal Executive Offices, and Zip Code)

 

(866) 620-8655

Registrant’s Telephone Number, Including Area Code

 

Not Applicable

 

(Former Name or Former Address, if Changed Since Last Report)

​

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

​

​

​

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

​

​

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

​

​

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

​

​

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

​

Securities registered pursuant to Section 12(b) of the Act:

​

​

​

​

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, par value $0.0001

VIRI

Nasdaq Capital Market

​

 

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

 

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

​

​

​

​

​

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Employee Salary and Director Compensation Reduction

On February 26, 2024, the Board of Directors (the “Board”) of Virios Therapeutics, Inc. (the “Company”) approved a 10% salary reduction for each employee of the Company, including each of the Company’s executive officers, effective March 1, 2024. In addition, on February 26, 2024, the Board approved a 10% reduction in the cash compensation of the non-employee members of the Board.

Stock Option Grant

In connection with the salary and compensation reductions described above, the Board approved the grant of options to purchase shares of the Company’s common stock (the “Stock Options”) pursuant to the Company’s Amended and Restated 2020 Equity Incentive Plan, as amended, to the executive officers and non-employee directors as follows:

Name

Title

Number of Options

Greg Duncan

Chairman and Chief Executive Officer

138,835

R. Michael Gendreau

Chief Medical Officer

88,085

Ralph Grosswald

Senior Vice President of Operations

62,568

Angela Walsh

Senior Vice President of Finance, Corporate Secretary and Treasurer

63,618

Abel De La Rosa

Director

3,959

Richard Burch

Director

2,917

David Keefer

Director

4,709

Richard J. Whitley

Director

4,000

John C. Thomas

Director

4,167

William L. Pridgen

Director

2,917

​

The grant of the Stock Options was effective on February 26, 2024, and the Stock Options will vest in full on February 26, 2025. The Stock Options have an exercise price of $0.357 per share.

​

​

​

​

​

​

​

​

​

2

​

SIGNATURES

​

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

​

​

​

​

 

VIRIOS THERAPEUTICS, INC.

 

 

 

 

By:

/s/ Angela Walsh

 

Name:

Angela Walsh

​

Title:

Senior Vice President of Finance, Corporate Secretary and Treasurer

February 27, 2024

​

​

​

​

​

​

​

​

​

3

 EX-101.SCH 2 tmb-20240226.xsd EX-101.SCH 00090 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 3 tmb-20240226_lab.xml EX-101.LAB EX-101.PRE 4 tmb-20240226_pre.xml EX-101.PRE XML 5 R1.htm IDEA: XBRL DOCUMENT v3.24.0.1
Document and Entity Information
Feb. 26, 2024
Document and Entity Information [Abstract]  
Document Type 8-K
Document Period End Date Feb. 26, 2024
Entity File Number 001-39811
Entity Registrant Name VIRIOS THERAPEUTICS, INC.
Entity Incorporation, State or Country Code DE
Entity Tax Identification Number 85-4314201
Entity Address, Address Line One 44 Milton Avenue
Entity Address, City or Town Alpharetta
Entity Address, State or Province GA
Entity Address, Postal Zip Code 30009
City Area Code 866
Local Phone Number 620-8655
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value $0.0001
Trading Symbol VIRI
Security Exchange Name NASDAQ
Entity Emerging Growth Company true
Entity Ex Transition Period false
Entity Central Index Key 0001818844
Amendment Flag false
EXCEL 7 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 8 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.0.1 html 1 23 1 false 0 0 false 0 false false R1.htm 00090 - Document - Document and Entity Information Sheet http://virios.com/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports tmb-20240226.xsd tmb-20240226_lab.xml tmb-20240226_pre.xml tmb-20240226x8k.htm http://xbrl.sec.gov/dei/2023 true false JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "tmb-20240226x8k.htm": { "nsprefix": "viri", "nsuri": "http://virios.com/20240226", "dts": { "schema": { "local": [ "tmb-20240226.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "labelLink": { "local": [ "tmb-20240226_lab.xml" ] }, "presentationLink": { "local": [ "tmb-20240226_pre.xml" ] }, "inline": { "local": [ "tmb-20240226x8k.htm" ] } }, "keyStandard": 23, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 24, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 23 }, "report": { "R1": { "role": "http://virios.com/role/DocumentDocumentAndEntityInformation", "longName": "00090 - Document - Document and Entity Information", "shortName": "Document and Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "Duration_2_26_2024_To_2_26_2024_uqPOXEagqE2KLDayyShOkw", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "tmb-20240226x8k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_2_26_2024_To_2_26_2024_uqPOXEagqE2KLDayyShOkw", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "tmb-20240226x8k.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://virios.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://virios.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Document and Entity Information [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://virios.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://virios.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://virios.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://virios.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://virios.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://virios.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://virios.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://virios.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://virios.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Ex Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r7" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://virios.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://virios.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://virios.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://virios.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://virios.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://virios.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://virios.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://virios.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://virios.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://virios.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://virios.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://virios.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 14 0001558370-24-001840-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001558370-24-001840-xbrl.zip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end XML 15 tmb-20240226x8k_htm.xml IDEA: XBRL DOCUMENT 0001818844 2024-02-26 2024-02-26 0001818844 false 8-K 2024-02-26 VIRIOS THERAPEUTICS, INC. DE 001-39811 85-4314201 44 Milton Avenue Alpharetta GA 30009 866 620-8655 false false false false Common Stock, par value $0.0001 VIRI NASDAQ true false